96574-01-5
96574-01-5 结构式
基本信息
丹酚酸 A
丹酚酸A对照品,
丹酚酸A(标准品)
丹酚酸A(丹参酚酸A)
丹参酚酸A, 来源于丹参根茎
SALVIANOLIC ACID A 丹酚酸A
(R)-3-(3,4-二羟基苯基)-2-((E)-3-(2-((E)-3,4-二羟基苯乙烯基)-3,4-二羟基苯基)丙烯酰基)氧基)丙酸
(2R)-3-(3,4-二羟基苯基)-2-[(E)-3-[2-[(E)-2-(3,4-二羟基苯基)乙烯基]-3,4-二羟基苯基]丙-2-烯酰]氧丙酸
Danphenolic acid A
SALVIANOLIC ACID A
Salvianolic acid A, >=98%
Salvianolic acid A hydrate
Dan phenolic acid A hydrate
Salvianolic acid A 96574-01-5
SALVIANOLIC ACID A 98.0% BY HPLC
Salvianolic acid A, froM Salvia Miltiorrhiza
Salvianolic acid A, 98%, from Salvia miltiorrhiza Bunge
物理化学性质
常见问题列表
|
MMP-9
|
A significant beneficial effect of Salvianolic acid A (SAA) is observed in the Salvianolic acid A treatment groups. Salvianolic acid A (20 mg/kg) could significantly prolonged the retention time of rats on the plate. While compared with sham operation group, the brain water content in model group significantly increases, which is attenuated significantly by Salvianolic acid A (10 and 20 mg/kg). Compared with the model group, Salvianolic acid A (5, 10, and 20 mg/kg) could maintain the normal structures of neurons and increase neurons number. It is also found that Salvianolic acid A (20 mg/kg) could significantly reduce I/R induced MMP-9 upregulation. While the MMP-2 expression is not significantly affected by Salvianolic acid A. Tissue inhibitors of metalloproteinases (TIMPs) could inhibit the activity of MMPs through high affinity binding to MMPs catalytic domain.